Internal Medicine, Hematology & Oncology · Wakefield, RI
NPI
1417954199
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
100 Kenyon Ave
Wakefield, RI, 02879
Phone (401) 783-6670
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
1,333 services
Medicare patients, 2024
440
Average age 76
Drug cost, 2024
$6.6M
2,780 prescriptions
Company payments, 2025
$8,658
From 40 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerald A Colvin was code 99214 (office e&m - established), 969 times for 388 patients. In total Gerald A Colvin billed 1,333 services in 23 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 969 | 388 | $91.89 | $89K |
| 99233 Hospital E&M - Subsequent | Facility | 75 | 24 | $90.05 | $6,753 |
| 99213 Office E&M - Established | Office | 65 | 52 | $62.64 | $4,072 |
| 96372 Injection Administration | Office | 46 | 16 | $10.49 | $482 |
| 99223 Hospital E&M - Initial | Facility | 33 | 31 | $134.86 | $4,450 |
| 99215 Office E&M - Established | Office | 27 | 22 | $133.51 | $3,605 |
| 99205 Office E&M - New | Office | 18 | 18 | $165.24 | $2,974 |
| 99204 Office E&M - New | Office | 15 | 15 | $115.68 | $1,735 |
| G0008 Administration of influenza virus vaccine | Office | 11 | 11 | $32.68 | $359 |
By year: 2022 $112K for 1,407 services; 2023 $119K for 1,516 services; 2024 $117K for 1,333 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gerald A Colvin prescribed most often to Medicare patients was Eliquis (Apixaban), with 91 prescriptions and refills. In total Gerald A Colvin wrote 2,780 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 91 | 127 | 21 | $71K |
| Oxycodone Hcl Generic | 82 | 82 | 14 | $2,289 |
| Prednisone Generic | 81 | 134 | 32 | $643 |
| Methylprednisolone Generic | 75 | 75 | 45 | $646 |
| Imbruvica Ibrutinib | 71 | 71 | Under 11 | $1.1M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 70 | 70 | 13 | $1,798 |
| Azithromycin Generic | 66 | 66 | 44 | $401 |
| Anastrozole Generic | 49 | 98 | 12 | $700 |
| Meloxicam Generic | 48 | 60 | 20 | $294 |
| Imatinib Mesylate Generic | 47 | 47 | Under 11 | $65K |
| Morphine Sulfate Er Morphine Sulfate | 47 | 47 | Under 11 | $678 |
| Jakafi Ruxolitinib Phosphate | 45 | 45 | Under 11 | $810K |
| Ondansetron Odt Ondansetron | 44 | 44 | 36 | $770 |
| Fluconazole Generic | 43 | 45 | 18 | $595 |
| Folic Acid Generic | 42 | 127 | 18 | $406 |
Brand drugs: - claims; generic drugs: 2,040 claims; opioid claims: 271.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerald A Colvin $8,658 ($8,658 in general payments such as food, travel and fees) from 40 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $3,376.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 18 | $3,376 |
| Janssen Biotech, Inc. JNJ | 13 | $1,647 |
| Sandoz Inc. SDZ.SW | 1 | $1,350 |
| Rigel Pharmaceuticals, Inc. RIGL | 10 | $339 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $143 |
| Pfizer Inc. PFE | 9 | $143 |
| Kite Pharma, Inc. GILD | 1 | $122 |
| Inspire Medical Systems, Inc. INSP | 5 | $117 |
| Abbvie Inc. ABBV | 4 | $116 |
| Merck Sharp & Dohme LLC MRK | 4 | $84.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.